Search Results

There are 81521 results for: content related to: Varenicline Potentiates Alcohol-Induced Negative Subjective Responses and Offsets Impaired Eye Movements

  1. Effects of Varenicline on Ethanol-Induced Conditioned Place Preference, Locomotor Stimulation, and Sensitization

    Alcoholism: Clinical and Experimental Research

    Volume 38, Issue 12, December 2014, Pages: 3033–3042, Noah R. Gubner, Carrie S. McKinnon and Tamara J. Phillips

    Article first published online : 7 JAN 2015, DOI: 10.1111/acer.12588

  2. You have full text access to this OnlineOpen article
    Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens

    British Journal of Pharmacology

    Volume 171, Issue 14, July 2014, Pages: 3420–3431, A A Feduccia, J A Simms, D Mill, H Y Yi and S E Bartlett

    Article first published online : 25 JUN 2014, DOI: 10.1111/bph.12690

  3. The effect of varenicline on the development and expression of nicotine-induced behavioral sensitization and cross-sensitization in rats

    Addiction Biology

    Volume 20, Issue 2, March 2015, Pages: 248–258, Wouter Goutier, Margreet B. Kloeze and Andrew C. McCreary

    Article first published online : 20 NOV 2013, DOI: 10.1111/adb.12108

  4. Longitudinal Associations Between Smoking Cessation Medications and Alcohol Consumption Among Smokers in the International Tobacco Control Four Country Survey

    Alcoholism: Clinical and Experimental Research

    Volume 37, Issue 5, May 2013, Pages: 804–810, Sherry A. McKee, Kelly C. Young-Wolff, Emily L. R. Harrison, K. Michael Cummings, Ron Borland, Christopher W. Kahler, Geoffrey T. Fong and Andrew Hyland

    Article first published online : 14 DEC 2012, DOI: 10.1111/acer.12041

  5. Exposure to the smoking cessation medicine varenicline during pregnancy: a prospective nationwide cohort study

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 10, October 2013, Pages: 1086–1092, Mira Harrison-Woolrych, Helen Paterson and Ming Tan

    Article first published online : 8 AUG 2013, DOI: 10.1002/pds.3489

  6. Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy

    Addiction

    Volume 108, Issue 8, August 2013, Pages: 1497–1502, Eva Kralikova, Alexandra Kmetova, Lenka Stepankova, Kamila Zvolska, Rachel Davis and Robert West

    Article first published online : 13 MAY 2013, DOI: 10.1111/add.12219

  7. Pharmacokinetics, Safety, and Tolerability Following Multiple Oral Doses of Varenicline Under Various Titration Schedules in Elderly Nonsmokers

    The Journal of Clinical Pharmacology

    Volume 51, Issue 4, April 2011, Pages: 492–501, Dr Qinying Zhao, Dr Elias Schwam, Dr Terence Fullerton, Ms Melissa O'Gorman and Dr Aaron H. Burstein

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270010370461

  8. Multiple-Dose Pharmacokinetics of the Selective Nicotinic Receptor Partial Agonist, Varenicline, in Healthy Smokers

    The Journal of Clinical Pharmacology

    Volume 46, Issue 12, December 2006, Pages: 1439–1448, Dr Hélène M. Faessel, Dr Megan A. Gibbs, Dr David J. Clark, Mr Kevin Rohrbacher, Dr Marilyn Stolar and Dr Aaron H. Burstein

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270006292624

  9. AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology

    British Journal of Pharmacology

    Volume 172, Issue 7, April 2015, Pages: 1834–1845, Andrea Cippitelli, Jinhua Wu, Kelly A Gaiolini, Daniela Mercatelli, Jennifer Schoch, Michelle Gorman, Alejandra Ramirez, Roberto Ciccocioppo, Taline V Khroyan, Dennis Yasuda, Nurulain T Zaveri, Conrado Pascual, Xinmin (Simon) Xie and Lawrence Toll

    Article first published online : 23 JAN 2015, DOI: 10.1111/bph.13034

  10. Pharmacokinetics, Safety, and Tolerability After Single and Multiple Oral Doses of Varenicline in Elderly Smokers

    The Journal of Clinical Pharmacology

    Volume 46, Issue 11, November 2006, Pages: 1234–1240, Dr Aaron H. Burstein, Dr Terence Fullerton, Dr David J. Clark and Dr Hélène M. Faessel

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270006291837

  11. Worsening Psychosis Induced by Varenicline in a Hospitalized Psychiatric Patient

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 7, July 2009, Pages: 852–857, Bethany A. DiPaula and Michele D. Thomas

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.29.7.852

  12. Single-Dose Pharmacokinetics of Varenicline, a Selective Nicotinic Receptor Partial Agonist, in Healthy Smokers and Nonsmokers

    The Journal of Clinical Pharmacology

    Volume 46, Issue 9, September 2006, Pages: 991–998, Dr Hélène M. Faessel, Dr Bill J. Smith, Dr Megan A. Gibbs, Dr Jason S. Gobey, Dr David J. Clark and Dr Aaron H. Burstein

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270006290669

  13. Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial

    Addiction

    Volume 109, Issue 9, September 2014, Pages: 1554–1563, Shadi Nahvi, Yuming Ning, Kate S. Segal, Kimber P. Richter and Julia H. Arnsten

    Article first published online : 27 JUN 2014, DOI: 10.1111/add.12631

  14. Human Abuse Liability of the Smoking Cessation Drug Varenicline in Smokers and Nonsmokers

    Clinical Pharmacology & Therapeutics

    Volume 83, Issue 4, April 2008, Pages: 607–614, SL McColl, AH Burstein, KR Reeves, CB Billing Jr, M Stolar and EM Sellers

    Article first published online : 20 FEB 2008, DOI: 10.1038/sj.clpt.6100510

  15. Interference with Smoking-Cessation Effects of Varenicline After Administration of Immediate-Release Amphetamine-Dextroamphetamine

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 10, October 2007, Pages: 1440–1445, Dr. Heather P. Whitley and Dr. Krystal L. Moorman

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.27.10.1440

  16. A review of cost-effectiveness of varenicline and comparison of cost-effectiveness of treatments for major smoking-related morbidities

    Journal of Evaluation in Clinical Practice

    Volume 17, Issue 2, April 2011, Pages: 288–297, Evelina A. Zimovetz, Koo Wilson, Miny Samuel and Stephen M. Beard

    Article first published online : 4 OCT 2010, DOI: 10.1111/j.1365-2753.2010.01439.x

  17. The effectiveness of varenicline medication guide for conveying safety information to patients: a REMS assessment survey

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 7, July 2013, Pages: 705–715, Cheryl Enger, Muhammad Younus, Kenneth R. Petronis, Jingping Mo, Robert Gately and John D. Seeger

    Article first published online : 24 JAN 2013, DOI: 10.1002/pds.3400

  18. Use of the Patient Health Questionnaire-2 to Predict Suicidal Ideations in Patients Taking Varenicline

    The American Journal on Addictions

    Volume 21, Issue 4, July/August 2012, Pages: 356–362, Christopher M. Cowan, Jennifer S. Wink and Kent J. DeZee

    Article first published online : 16 MAY 2012, DOI: 10.1111/j.1521-0391.2012.00243.x

  19. Lack of Pharmacokinetic and Pharmacodynamic Interactions Between a Smoking Cessation Therapy, Varenicline, and Warfarin: An In Vivo and In Vitro Study

    The Journal of Clinical Pharmacology

    Volume 47, Issue 11, November 2007, Pages: 1421–1429, Dr Aaron H. Burstein, Dr David J. Clark, Ms Melissa O'Gorman, Dr Susan A. Willavize, Mr Timothy G. Brayman, Mr G. Scott Grover, Mr Robert L. Walsky, Dr R. Scott Obach and Dr Hélène M. Faessel

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270007307574

  20. The Effects of Extended Pre-Quit Varenicline Treatment on Smoking Behavior and Short-Term Abstinence: A Randomized Clinical Trial

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 2, February 2012, Pages: 172–180, L W Hawk Jr, R L Ashare, S F Lohnes, N J Schlienz, J D Rhodes, S T Tiffany, J C Gass, K M Cummings and M C Mahoney

    Article first published online : 30 NOV 2011, DOI: 10.1038/clpt.2011.317